Acetyl Cysteine ??Injection in knee and hip for Arthrosis treatment

Phase 3

Recruiting

• Conditions: Knee Osteoarthritis; Hip Osteoarthritis; C05.550.114.606

• Registration Number: RBR-4nvxt7x
• Lead Sponsor: Santa Casa de Misericórdia de Belo Horizonte - Ensino e Pesquisa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-06-23
• Last Update Posted: 26 June 2023
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients of both sexes; no age limits; symptomatic knee osteoarthritis for more than 6 months and
with access to physical therapy

Exclusion Criteria

Patients with a history of joint surgeries; use of dual antidepressants up to 60 days before the initial assessment; regular use of therapeutic or prophylactic anticoagulants; use of gabapentinoids up to 60 days before the initial evaluation; use of oral or intramuscular corticosteroid therapy up to 60 days before the assessment; previous joint infiltration up to 12 months before the initial evaluation; neurological deficits; disabling systemic disease; chemical immunosuppression or secondary to microbiological agents; use of antirheumatic agents; active infectious conditions; past history of joint infection; diabetes mellitus and glycated hemoglobin greater than 7.0% in the last 6 months

Study & Design

• Study Type: Intervention
• Study Design: Not specified